CLASSIFICATION GENERIC NAME: Acetylcysteine Brand Name: Parvolex

DOSAGE 600 gram

ACTION Acetylcystein e medication belong to Respiratory inhalant/Muc olytic class. Acetylcystein e decreases thickness of mucous secretions in lung.

INDICATION Acetylcysteine is often used to dissolve mucus and to facilitate expectoration during respirato ry diseases. While there are a number of open and controlled studies that suggest a considerable benefit, there are other controlled studies that do not demonstrate a significant effect. A formal meta-analysis does not exist; however, many specialists consider the beneficial effect of acetylcysteine marginal.

CONTRAINDICATION MAO inhibitor therapy within 14 days initiating therapy; severe hypertension; severe. Coronary artery disease, hypersensitivity to pseudoedephrine, acrivastine or any component; renal impairment.

ADVERSE EFFECT Like other medicines, Acetylcysteine can cause side effects. Some of the more common side effects of Acetylcysteine include Tachycardia, hypotension, hypertension, chest tightness (oral); tachycardia, chest tightness Drowsiness Rash, pruritus, angioedema (oral); pruritus, rash, flushing Rhinorrhea (oral); ear pain, pharyngitis, throat tightness Nausea, vomiting, stomatitis (oral); nausea, vomiting Bronchospasm, bronchial irritation (oral); rhinorrhea, rhonchi Fever, clamminess.

NURSING RESPONSIBILITIES Monitor effectiveness of therapy and advent of adverse/allergic effects. Instruct Patient in appropriate use and adverse effects to report.

CLASSIFICATION GENERIC NAME: Acetylcysteine Brand Name: Parvolex

DOSAGE 600 gram

ACTION Acetylcystein e medication belong to Respiratory inhalant/Muc olytic class. Acetylcystein e decreases thickness of mucous secretions in lung.

INDICATION Acetylcysteine is often used to dissolve mucus and to facilitate expectoration during respirato ry diseases. While there are a number of open and controlled studies that suggest a considerable benefit, there are other controlled studies that do not demonstrate a significant effect. A formal meta-analysis does not exist; however, many specialists consider the beneficial effect of acetylcysteine marginal.

CONTRAINDICATION MAO inhibitor therapy within 14 days initiating therapy; severe hypertension; severe. Coronary artery disease, hypersensitivity to pseudoedephrine, acrivastine or any component; renal impairment.

ADVERSE EFFECT Like other medicines, Acetylcysteine can cause side effects. Some of the more common side effects of Acetylcysteine include Tachycardia, hypotension, hypertension, chest tightness (oral); tachycardia, chest tightness Drowsiness Rash, pruritus, angioedema (oral); pruritus, rash, flushing Rhinorrhea (oral); ear pain, pharyngitis, throat tightness Nausea, vomiting, stomatitis (oral); nausea, vomiting Bronchospasm, bronchial irritation (oral); rhinorrhea, rhonchi Fever, clamminess.

NURSING RESPONSIBILITIES Monitor effectiveness of therapy and advent of adverse/allergic effects. Instruct Patient in appropriate use and adverse effects to report.

CLASSIFICATION GENERIC NAME: Acetylcysteine Brand Name: Parvolex

DOSAGE 600 gram

ACTION Acetylcystein e medication belong to Respiratory inhalant/Muc olytic class. Acetylcystein e decreases thickness of mucous secretions in lung.

INDICATION Acetylcysteine is often used to dissolve mucus and to facilitate expectoration during respirato ry diseases. While there are a number of open and controlled studies that suggest a considerable benefit, there are other controlled studies that do not demonstrate a significant effect. A formal meta-analysis does not exist; however, many specialists consider the beneficial effect of acetylcysteine marginal.

CONTRAINDICATION MAO inhibitor therapy within 14 days initiating therapy; severe hypertension; severe. Coronary artery disease, hypersensitivity to pseudoedephrine, acrivastine or any component; renal impairment.

ADVERSE EFFECT Like other medicines, Acetylcysteine can cause side effects. Some of the more common side effects of Acetylcysteine include Tachycardia, hypotension, hypertension, chest tightness (oral); tachycardia, chest tightness Drowsiness Rash, pruritus, angioedema (oral); pruritus, rash, flushing Rhinorrhea (oral); ear pain, pharyngitis, throat tightness Nausea, vomiting, stomatitis (oral); nausea, vomiting Bronchospasm, bronchial irritation (oral); rhinorrhea, rhonchi

NURSING RESPONSIBILITIES Monitor effectiveness of therapy and advent of adverse/allergic effects. Instruct Patient in appropriate use and adverse effects to report.

Fever, clamminess.

CLASSIFICATION GENERIC NAME: Acetylcysteine Brand Name: Parvolex

DOSAGE 600 gram

ACTION Acetylcystein e medication belong to Respiratory inhalant/Muc olytic class. Acetylcystein e decreases thickness of mucous secretions in lung.

INDICATION Acetylcysteine is often used to dissolve mucus and to facilitate expectoration during respirato ry diseases. While there are a number of open and controlled studies that suggest a considerable benefit, there are other controlled studies that do not demonstrate a significant effect. A formal meta-analysis does not exist; however, many specialists consider the beneficial effect of acetylcysteine marginal.

CONTRAINDICATION MAO inhibitor therapy within 14 days initiating therapy; severe hypertension; severe. Coronary artery disease, hypersensitivity to pseudoedephrine, acrivastine or any component; renal impairment.

ADVERSE EFFECT Like other medicines, Acetylcysteine can cause side effects. Some of the more common side effects of Acetylcysteine include Tachycardia, hypotension, hypertension, chest tightness (oral); tachycardia, chest tightness Drowsiness Rash, pruritus, angioedema (oral); pruritus, rash, flushing Rhinorrhea (oral); ear pain, pharyngitis, throat tightness Nausea, vomiting, stomatitis (oral); nausea, vomiting Bronchospasm, bronchial irritation (oral);

NURSING RESPONSIBILITIES Monitor effectiveness of therapy and advent of adverse/allergic effects. Instruct Patient in appropriate use and adverse effects to report.

rhinorrhea, rhonchi Fever, clamminess.